Compare CUBE & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CUBE | DVA |
|---|---|---|
| Founded | 2004 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Misc Health and Biotechnology Services |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.0B |
| IPO Year | 2004 | 2002 |
| Metric | CUBE | DVA |
|---|---|---|
| Price | $39.53 | $150.13 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 4 |
| Target Price | $44.00 | ★ $156.75 |
| AVG Volume (30 Days) | ★ 1.9M | 584.2K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.43% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.46 | ★ 9.84 |
| Revenue | $1,123,110,000.00 | ★ $13,643,069,000.00 |
| Revenue This Year | $0.66 | $3.85 |
| Revenue Next Year | $2.82 | $3.07 |
| P/E Ratio | $26.74 | ★ $15.27 |
| Revenue Growth | 5.33 | ★ 6.46 |
| 52 Week Low | $35.09 | $101.00 |
| 52 Week High | $44.13 | $159.42 |
| Indicator | CUBE | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 55.97 | 50.24 |
| Support Level | $38.41 | $144.98 |
| Resistance Level | $41.01 | $152.31 |
| Average True Range (ATR) | 0.78 | 3.31 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 60.25 | 53.98 |
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Majority of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.